MX2018001905A - Metodos para el tratamiento del virus de hepatitis c (vhc). - Google Patents
Metodos para el tratamiento del virus de hepatitis c (vhc).Info
- Publication number
- MX2018001905A MX2018001905A MX2018001905A MX2018001905A MX2018001905A MX 2018001905 A MX2018001905 A MX 2018001905A MX 2018001905 A MX2018001905 A MX 2018001905A MX 2018001905 A MX2018001905 A MX 2018001905A MX 2018001905 A MX2018001905 A MX 2018001905A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- methods
- weeks
- compound
- pharmaceutically acceptable
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 abstract 1
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 229940125782 compound 2 Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 229960000329 ribavirin Drugs 0.000 abstract 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/431,906 US11484534B2 (en) | 2013-03-14 | 2017-02-14 | Methods for treating HCV |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018001905A true MX2018001905A (es) | 2018-11-09 |
Family
ID=61192811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001905A MX2018001905A (es) | 2017-02-14 | 2018-02-14 | Metodos para el tratamiento del virus de hepatitis c (vhc). |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3360555A1 (https=) |
| JP (1) | JP2018131439A (https=) |
| CN (1) | CN108421029A (https=) |
| AU (1) | AU2018201011A1 (https=) |
| BR (1) | BR102018002956A2 (https=) |
| CA (1) | CA2994496A1 (https=) |
| MX (1) | MX2018001905A (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005058821A1 (en) * | 2003-12-11 | 2005-06-30 | Schering Corporation | Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| JP5857053B2 (ja) | 2010-09-21 | 2016-02-10 | エナンタ ファーマシューティカルズ インコーポレイテッド | 大環式プロリン由来ｈｃｖセリンプロテアーゼ阻害剤 |
| DE202012012955U1 (de) | 2011-10-21 | 2014-07-14 | Abbvie Inc. | Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV |
| EP2583677A3 (en) * | 2011-10-21 | 2013-07-03 | Abbvie Inc. | Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon. |
| KR20210013344A (ko) * | 2013-03-14 | 2021-02-03 | 애브비 인코포레이티드 | C형 간염 치료용 2가지 항바이러스제의 병용물 |
| JP6563894B2 (ja) * | 2013-03-14 | 2019-08-21 | アッヴィ・インコーポレイテッド | Ｈｃｖ患者を治療するための直接的に作用する抗ウイルス剤とリバビリンとの併用 |
| US10286029B2 (en) * | 2013-03-14 | 2019-05-14 | Abbvie Inc. | Method for treating HCV |
| JP6808660B2 (ja) * | 2015-07-08 | 2021-01-06 | アッヴィ・インコーポレイテッド | Ｈｃｖを処置するための方法 |
-
2018
- 2018-02-09 JP JP2018021874A patent/JP2018131439A/ja active Pending
- 2018-02-09 CA CA2994496A patent/CA2994496A1/en active Pending
- 2018-02-12 AU AU2018201011A patent/AU2018201011A1/en not_active Abandoned
- 2018-02-12 EP EP18156337.0A patent/EP3360555A1/en not_active Withdrawn
- 2018-02-13 CN CN201810149405.XA patent/CN108421029A/zh active Pending
- 2018-02-14 MX MX2018001905A patent/MX2018001905A/es unknown
- 2018-02-15 BR BR102018002956A patent/BR102018002956A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018201011A1 (en) | 2018-08-30 |
| CN108421029A (zh) | 2018-08-21 |
| BR102018002956A2 (pt) | 2018-10-30 |
| CA2994496A1 (en) | 2018-08-14 |
| EP3360555A1 (en) | 2018-08-15 |
| JP2018131439A (ja) | 2018-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020005054A (es) | Combinacion de dos agentes antivirales para el tratamiento de hepatitis c. | |
| MX388482B (es) | Métodos para tratar el virus de la hepatitis c. | |
| EA201890507A1 (ru) | Комбинация противовирусных препаратов прямого действия и рибавирина для лечения пациентов с hcv | |
| MX2018000240A (es) | Metodos para tratar el vhc. | |
| PH12014502848A1 (en) | Methods for treating hcv comprising at least two direct acting antiviral agent, ribavirin but not interferon | |
| PH12018550201A1 (en) | Hepatitis b antiviral agents | |
| PH12014500833A1 (en) | Methods for treating hcv | |
| PH12018550150A1 (en) | Elimination of hepatitis b virus with antiviral agents | |
| RU2015114543A (ru) | Способы лечения гепатита с | |
| MX2016012722A (es) | Metodos para tratar el virus de la hepatitis c. | |
| PH12021550632A1 (en) | Monomer and multimeric anti-hbv agents | |
| MX2021002147A (es) | Tratamiento de la infección por virus de la hepatitis delta con interferón lambda. | |
| RU2015114566A (ru) | Способы лечения гепатита с | |
| MX2022006742A (es) | Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter. | |
| WO2016090107A3 (en) | Treatment of hepatitis delta virus infection | |
| MX2020001422A (es) | Metodos para el tratamiento de hcv. | |
| MX2018001905A (es) | Metodos para el tratamiento del virus de hepatitis c (vhc). | |
| AU2019384793A8 (en) | Methods for treating acute HCV | |
| NZ631789A (en) | Combination of direct acting antiviral agents and ribavirin for treating hcv patients | |
| UA101772U (uk) | Спосіб лікування хронічного вірусного гепатиту с із супутньою неалкогольною жировою хворобою печінки | |
| RU2008142658A (ru) | Способ лечения инфекционных поражений нервной системы |